Article
Effects of octreotide therapy in progressive head and neck paragangliomas: case series.
Head & neck - 1 Dec 2013
van Hulsteijn Leonie T, van Duinen Nicolette, Verbist Berit M, Jansen Jeroen C, van der Klaauw Agatha A, Smit Jan W A, Corssmit Eleonora P M
Abstract excerpt
BACKGROUND: Octreotide, a somatostatin analog, may be beneficial in the treatment of head and neck paragangliomas (HNPGLs). METHODS: We conducted a nonblinded, prospective intervention study. During 1 year, patients received a monthly intramuscular injection of 30 mg octreotide. Pretreatment and posttreatment tumor volumes were assessed by MRI, urinary catecholamine secretion was measured, and HNPGL-related signs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
